---
figid: PMC5854933__br-08-03-0215-g00
figtitle: WNT pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5854933
filename: br-08-03-0215-g00.jpg
figlink: /pmc/articles/PMC5854933/figure/f1-br-0-0-1045/
number: F1
caption: Schematic diagram depicting the proposed WNT pathway antagonists, inhibitors
  and modulators. The WNT receptor and its downstream targets are considered as promising
  therapeutic targets for the treatment of mucinous ovarian cancer. Arrows indicate
  modulators. LRP5/6, lipoprotein receptor-related protein 5/6; Fzd, Frizzled; sFzd7,
  soluble Fzd7 peptide; RNF43, ring finger protein 43; DKK, Dickkopf1; DVL, Dishevelled;
  TMEM88, transmembrane protein 88; HUWE1, HECT, UBA and WWE domain-containing 1;
  WWOX, WW domain-containing oxidoreductase; DACT1, dishevelled-binding antagonist
  of β-catenin; GSK3β, glycogen synthase kinase 3β; DIF, differentiation-inducing
  factor; CK1, casein kinase 1; APC, adenomatous polyposis coli; CDX2, caudal type
  homeobox 2; TCF, T-cell factor; TNIK, Traf2 and Nck-interacting protein kinase.
papertitle: Potential signaling pathways as therapeutic targets for overcoming chemoresistance
  in mucinous ovarian cancer.
reftext: Emiko Niiro, et al. Biomed Rep. 2018 Mar;8(3):215-223.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8451996
figid_alias: PMC5854933__F1
figtype: Figure
redirect_from: /figures/PMC5854933__F1
ndex: e46684bf-df21-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5854933__br-08-03-0215-g00.html
  '@type': Dataset
  description: Schematic diagram depicting the proposed WNT pathway antagonists, inhibitors
    and modulators. The WNT receptor and its downstream targets are considered as
    promising therapeutic targets for the treatment of mucinous ovarian cancer. Arrows
    indicate modulators. LRP5/6, lipoprotein receptor-related protein 5/6; Fzd, Frizzled;
    sFzd7, soluble Fzd7 peptide; RNF43, ring finger protein 43; DKK, Dickkopf1; DVL,
    Dishevelled; TMEM88, transmembrane protein 88; HUWE1, HECT, UBA and WWE domain-containing
    1; WWOX, WW domain-containing oxidoreductase; DACT1, dishevelled-binding antagonist
    of β-catenin; GSK3β, glycogen synthase kinase 3β; DIF, differentiation-inducing
    factor; CK1, casein kinase 1; APC, adenomatous polyposis coli; CDX2, caudal type
    homeobox 2; TCF, T-cell factor; TNIK, Traf2 and Nck-interacting protein kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP6
  - LRP5
  - FZD7
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD8
  - FZD9
  - DKK1
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - WWOX
  - DACT1
  - HUWE1
  - TMEM88
  - TNF
  - GSK3B
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CDX2
  - CTNNB1
  - TNIK
  - HNF4A
  - MYC
  - Salinomycin
  - Prodigiosin
  - Prodigiosin 3289-8625
  - NSC668036
  - Niclosamide
  - Polyphyllin
  - Mebendazole
  - NCB-0846
  - Pyrvinium
---
